Omni Peptides

Ipamorelin

Dhs. 320.00 AED

Sale Sold out

VIAL

Freeze-dried powder in a sealed glass vial. Reconstitute with bacteriostatic water and administer via syringe. The most versatile and cost-effective research format.

RECONSTITUTION & SYRINGE REQUIRED

CARTRIDGE

Pre-filled and ready to administer. Slides into a reusable pen injector — no measuring or mixing required. Clean, discreet, and consistent across research protocols.

REQUIRES COMPATIBLE PEN INJECTOR

NASAL

Delivered via mucosal absorption — no needles required. A popular choice for research protocols where needle-free administration is preferred.

NEEDLE-FREE — SPRAY & GO

PEN

An all-in-one auto-injector with the cartridge pre-loaded. Dial, click, and administer. Optimal for high-frequency research protocols requiring precise, repeatable dosing.

DIAL, CLICK & INJECT — NO PREP

Vials are freeze-dried (lyophilised) powder — kept refrigerated unopened, they remain stable for up to 2 years.

Cartridges, nasal sprays, and pens arrive pre-filled as liquid, must be kept refrigerated at all times, and carry a Beyond Use Date — typically 4–8 weeks from receipt. Please refer to the BUD on the label.

Size 10mg 5mg

↑ GH/IGF-1, better sleep & recovery, body recomposition

Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue (GHS) that functions as a potent agonist of the ghrelin receptor (GHS-R1a). This research compound has attracted substantial scientific interest due to its ability to stimulate pulsatile endogenous growth hormone (GH) release from the anterior pituitary with minimal impact on other hormones such as prolactin, cortisol, or adrenocorticotropic hormone (ACTH). Preliminary and advanced preclinical studies indicate that Ipamorelin may promote lipolysis, support lean body mass, enhance recovery processes, and exhibit favorable pharmacokinetic properties including high selectivity and stability. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of GH axis modulation, body composition, tissue repair, and age-related endocrine changes. As a research-grade compound, Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its clean pharmacological profile, lack of significant appetite stimulation compared to other GHS compounds, and utility in advancing understanding of selective ghrelin receptor agonism in anabolic and metabolic research.

Molecular Formula

C₃₈H₄₉N₉O₅

Molecular Weight

711.85 g/mol

Sequence

Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid; D-2-Nal = D-2-naphthylalanine; C-terminal amidation)

Research Applications

Growth Hormone Secretion and Pulsatility
Preclinical investigations demonstrate that Ipamorelin elicits robust, dose-dependent, and pulsatile GH release via specific activation of pituitary GHS-R1a receptors. Studies highlight its ability to mimic natural GH pulses while avoiding the broad hormonal perturbations seen with non-selective secretagogues.
Body Composition and Anabolic Effects
Research shows Ipamorelin promotes increases in lean muscle mass, improves nitrogen balance, and supports protein synthesis in various animal models. It has been explored for potential benefits in sarcopenia, cachexia, and recovery from catabolic states.
Fat Metabolism and Lipolysis
Ipamorelin enhances lipolytic activity and reduces fat accumulation in preclinical obesity and metabolic models, often in combination with other peptides. Investigations assess its role in improving body composition without inducing significant hyperglycemia or insulin resistance.
Tissue Repair and Recovery
Studies indicate potential benefits in accelerating wound healing, tendon and cartilage repair, and bone metabolism through elevated GH/IGF-1 axis activity. Research explores its applications in models of injury, aging, and post-surgical recovery.
Neuroprotection and Cognitive Support
Emerging preclinical data suggest neuroprotective properties, including possible modulation of brain-derived neurotrophic factor (BDNF) and improved outcomes in models of neurodegeneration, traumatic brain injury, and age-related cognitive decline.

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.